Author:
Risslegger B.,Zoran T.,Lackner M.,Aigner M.,Sánchez-Reus F.,Rezusta A.,Chowdhary A.,Taj-Aldeen S.J.,Arendrup M.C.,Oliveri S.,Kontoyiannis D.P.,Alastruey-Izquierdo A.,Lagrou K.,Lo Cascio G.,Meis J.F.,Buzina W.,Farina C.,Drogari-Apiranthitou M.,Grancini A.,Tortorano A.M.,Willinger B.,Hamprecht A.,Johnson E.,Klingspor L.,Arsic-Arsenijevic V.,Cornely O.A.,Meletiadis J.,Prammer W.,Tullio V.,Vehreschild J.-J.,Trovato L.,Lewis R.E.,Segal E.,Rath P.-M.,Hamal P.,Rodriguez-Iglesias M.,Roilides E.,Arikan-Akdagli S.,Chakrabarti A.,Colombo A.L.,Fernández M.S.,Martin-Gomez M.T.,Badali H.,Petrikkos G.,Klimko N.,Heimann S.M.,Houbraken J.,Uzun O.,Edlinger M.,Fuente S. de la,Lass-Flörl C.
Funder
Astellas
Pfizer
Austrian Science Fund
Gilead Sciences
Schering Plough
Bio-Rad
Astellas Pharma
Merck
Amplyx
Cidara
Basilea
Gilead
United Medical
German Federal Ministry of Research
Actelion
AstraZeneca
Bayer
Duke University
Leeds University
Melinta Therapeutics
Seres Therapeutics
Schering-Plough
Sharpe & Dohme
Subject
Infectious Diseases,Microbiology (medical),General Medicine